BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37526083)

  • 21. Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease.
    Tijaro-Ovalle NM; Karantanos T; Wang HT; Boussiotis VA
    Front Immunol; 2019; 10():295. PubMed ID: 30891031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of T-cell-suppressive PD-L1
    Baur R; Karl F; Böttcher-Loschinski R; Stoll A; Völkl S; Gießl A; Flamann C; Bruns H; Schlötzer-Schrehardt U; Böttcher M; Schewe DM; Fischer T; Jitschin R; Mackensen A; Mougiakakos D
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36898735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects.
    Deeg HJ
    Int J Hematol; 2003 Jan; 77(1):15-21. PubMed ID: 12568295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.
    Casucci M; Perna SK; Falcone L; Camisa B; Magnani Z; Bernardi M; Crotta A; Tresoldi C; Fleischhauer K; Ponzoni M; Gregori S; Caligaris Cappio F; Ciceri F; Bordignon C; Cignetti A; Bondanza A; Bonini C
    Mol Ther; 2013 Feb; 21(2):466-75. PubMed ID: 23299798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
    Gao Y; Shan W; Gu T; Zhang J; Wu Y; Li X; Zeng X; Zhou H; Chen Z; Xiao H
    Front Immunol; 2021; 12():785774. PubMed ID: 34987512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
    Bertaina A; Roncarolo MG
    Front Immunol; 2019; 10():1342. PubMed ID: 31354695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation.
    Darlak KA; Wang Y; Li JM; Harris WA; Owens LM; Waller EK
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1331-9. PubMed ID: 23810844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.
    Imado T; Iwasaki T; Kuroiwa T; Sano H; Hara H
    Transplantation; 2004 Feb; 77(3):391-8. PubMed ID: 14966413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.
    Liang Y; Liu C; Djeu JY; Zhong B; Peters T; Scharffetter-Kochanek K; Anasetti C; Yu XZ
    Blood; 2008 Jan; 111(2):954-62. PubMed ID: 17928532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.
    Litvinova E; Maury S; Boyer O; Bruel S; Benard L; Boisserie G; Klatzmann D; Cohen JL
    Blood; 2002 Sep; 100(6):2020-5. PubMed ID: 12200361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation].
    Chang YJ; Huang XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 41(2):208-11. PubMed ID: 19377632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
    van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential role of γδ T cells after allogeneic HCT for leukemia.
    Handgretinger R; Schilbach K
    Blood; 2018 Mar; 131(10):1063-1072. PubMed ID: 29358176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.
    Vaeth M; Bäuerlein CA; Pusch T; Findeis J; Chopra M; Mottok A; Rosenwald A; Beilhack A; Berberich-Siebelt F
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1125-30. PubMed ID: 25583478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation.
    van der Straaten HM; Fijnheer R; Nieuwenhuis HK; van de Winkel JG; Verdonck LF
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):206-12. PubMed ID: 15744239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway.
    Sofi MH; Tian L; Schutt S; Khan I; Choi HJ; Wu Y; Bastian D; Ticer T; Kassir MF; Atilgan FC; Kim J; Sui X; Zivkovic A; Mehrotra S; O'Bryan JP; Stark H; Martin PJ; Ogretmen B; Yu XZ
    Leukemia; 2022 Jul; 36(7):1907-1915. PubMed ID: 35513703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
    Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease.
    Cooke KR; Olkiewicz K; Erickson N; Ferrara JL
    J Endotoxin Res; 2002; 8(6):441-8. PubMed ID: 12697087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.